Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Banco Santander $2.25 billion offering of senior non-preferred notes
We advised Banco Santander on the SEC-registered investment-grade debt offering
Tempur Sealy $800 million senior notes offering
We advised the initial purchasers on the high-yield debt offering
Charles River Laboratories International $1 billion senior notes offering
We advised Charles River Laboratories on the high-yield debt offering
Anthem $3.5 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
Bank of America €1.5 billion fixed/floating-rate senior notes offering
We advised the joint-lead managers on the offering pursuant to the issuer’s euro medium-term note program
Anglo American $1 billion notes offering
We advised the underwriters on the Rule 144A senior notes offering
European Biotech Acquisition $120 million IPO
We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing
Sasol $1.5 billion notes offering
We advised the underwriters on the SEC-registered offering
Macy’s $500 million senior notes offering, tender offer and consent solicitation
We advised the initial purchasers on the high-yield notes offering, concurrent tender offer and related consent solicitation
Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares